1. HBW Insight
  2. >>Health
  3. >>Business

NanoBio Nasal Antiseptic Launch Accelerated As COVID-19 Spikes Demand For Personal Sanitizers

 
• By Malcolm Spicer

“When COVID-19 hit, we really decided to accelerate plans,” says BlueWillow CEO Dave Peralta. NanoBio Protect contains OTC monograph ingredient benzalkonium chloride in a proprietary nanotechnology, alcohol-free formulation to help reduce germs on skin inside and around the nose that could cause infections.

Blue Willow
BlueWillow's NanoBio Protect nasal antiseptic solution contains benzalkonium chloride in a nanotech and alcohol-free formulation to help reduce germs on skin inside and around the nose that could cause infections.

BlueWillow Biologics Inc. was developing an OTC nasal antiseptic gel with its proprietary nanotechnology formulation before a novel coronavirus gripped the US and demand for personal sanitizers spiked.

“When COVID-19 hit, we really decided to accelerate plans,” says Dave Peralta, CEO of the Ann Arbor, MI, firm developing topical antiseptic and anti-infective products and intranasal vaccines based on the

More from Business

More from Health